Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Use of Limb Cryocompression to Reduce Taxane-induced Peripheral Neuropathy

NCT07064798 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT07064798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07064798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Use of Limb Cryocompression to Reduce Taxane-induced Peripheral Neuropathy
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
October 22, 2025
Completion date
August 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy, cipn - chemotherapy-induced peripheral neuropathy, taxane-induced peripheral neuropathy